Kajaria Ceramics Limited was incorporated in 1985 as a manufacturer of floor & wall tiles by Mr. Ashok Kajaria in technical collaboration with Todagres SA, Spain.
It is the largest manufacturer of ceramic/vitrified tiles in India &
the 8th largest in the world.
(2/17)
Tile Industry:
India occupies the second position
in the global tile industry. While
the residential sector is the primary
consumer of tiles, demand from the commercial sector is growing
at a healthy clip owing to sustained
investments by the govt &
private players.
(3/17)
Kajaria Product Verticals:
The company’s
manufacturing facilities are in Sikanderabad (UP), Gailpur & Malootana (Rajasthan) and Srikalahasti (Andhra
Pradesh), with an aggregate capacity of 62.2 msm. It also has 22.6 msm capacity under various subsidiaries/JVs.
(4/17)
Brands:
• Kajaria
• Kerovit
• Kajaria Ply
Brand Ambassadors:
• Akshay Kumar
• Ranveer Singh
• Anushka Sharma
(5/17)
Ind Growth Drivers:
• Sops for Home improvement :
The ceiling on loans for carrying out repairs, additions or alterations to their house had now been revised to ₹10 lakh in metropolitan centres & ₹6 lakh in other
centres. Up from ₹5lakh and ₹2lakh respectively
(6/17)
Strong Underlying Demand:
As per the estimates of IMARC Group’s report, the Indian ceramic tiles market is expected to grow at a CAGR of 5-7% during the forecast period of 2022-2027.
The real estate demand is expected to increase by 15-18 million sq. ft. by
2025.
(7/17)
Revenue classification by geography:
• North India (Biggest Market) : 40% share in revenue
• South India: (30-35)%
• West India: (25-30)%
• East India: 10%
Retail constitutes around 70-80% of the revenues for KCL.
(8/17)
Key Strengths:
• Pan-India presence -
KCL is the largest player in the
domestic tiles industry with a track record of over three decades. It has a pan-India distribution network of 1,700 dealers; 10,000 touchpoints.
(9/17)
• Scale of operations -
KCL has reported steady revenue growth over the years driven by A steady retail demand & increasing penetration in tier-II & tier-III markets, with revenues increasing to ₹3,705 crore in FY22 (+33% YoY) & ₹2,086 crore in H1 FY2023 (+36% YoY).
(10/17)
Cash flow:
Company has largely stayed away from external debt for funding its capex requirements. This is due to the strong and consistent CF generation.
It has around ₹338cr of cash & liquid investments as on Sept 30, 2022, resulting in a net negative debt position.
(11/17)
Weaknesses:
Competition:
The growing presence of large, organised players and numerous mid & small sized players, along with high pace of capacity addition, in the recent past, has intensified competition in the tiles industry. We expect an uptick in marketing expenses
(12/17)
• Susceptibility to RM & Fuel Prices:
Raw materials and natural gas form a major part of the cost structure for Kajaria. This is clearly reflected in the moderation of its profitability which is seeing a downtrend from 18.5% in FY21 to 16.5% in FY22 to 13.6% in H1FY23
(13/17)
However, we expect that the peak in prices are behind us and since Kajaria is the market leader in the sector. It commands a pricing power and thus is in a better position than it’s competitors.
We expect an improvement in profitability from here on.
(14/17)
Performance:
The quarter saw flattish volume growth but a decent revenue growth of 11% as compared to
Q2FY22 owing to increasing input cost.
(15/17)
Expansion Plans:
Source: Investor Presentation:
(16/17)
Key Ratios and Numbers:
• Market Cap: ₹ 17,754 Cr
• Stock P/E: 46.5 vs Ind P/E: 32.54
• RoE: 14.9%
• PEG: 5.70
• Sales 3 year CAGR: 7.82%
• Price to Sales: 4.17
• NPM Last year: 10.4%
• OPM Q2FY23: 12%
• D/E: 0.10
• Dividend Yield: 0.98%
(17/17)
Do you expect a strong & consistent volume growth for Tiles Industry in medium term?
SCIL is a wholly owned subsidiary of Japanese chemical major, Sumitomo Chemical Company Limited Japan (SCCL), engaged in the manufacturing & marketing of crop protection formulations based on the active ingredients procured from SCCL and third parties.
(2/17)
About SCCL:
SCCL is a leading Japanese research driven diversified chemical company listed on the Tokyo Stock Exchange with consolidated sales revenue of more than US$ 22.5 bn.
It holds 12,600+ Patents of which ~34% are in Health & Crop Science
SEML manufactures iron pellets, sponge iron, billets, wire rods and wires, along with ferro alloys and eco-friendly fly ash brick. The group has thermal power plants and a waste-heat recovery boiler to generate power that is largely used for captive consumption.
IPL is engaged in the manufacturing of various types of pesticides (technical & formulations) & pharma intermediates.
Pesticides contributed about 95% of total sales, while pharmaceutical intermediates contributed about 5% to total sales of the company in FY22.
(2/18)
Pesticides:
According to IMARC Group, the market will reach INR 320 billion by 2027, with a CAGR of 7.07% from 2022 to 2027 driven by the need to improve total agricultural production. Pests & illnesses consume approximately 20-25 % of the entire food produced in India.